Tudor Investment Corp
BLPH

Tudor Investment Corp’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Tudor Investment Corp’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-20,000
Closed -$18K – 3123
2022
Q4 		$18K Hold
20,000
– – ﹤0.01% 2271
2022
Q3 		$22K Hold
20,000
– – ﹤0.01% 2207
2022
Q2 		$25K Hold
20,000
– – ﹤0.01% 2005
2022
Q1 		$47K Hold
20,000
– – ﹤0.01% 1867
2021
Q4 		$62K Hold
20,000
– – ﹤0.01% 2258
2021
Q3 		$81K Hold
20,000
– – ﹤0.01% 2370
2021
Q2 		$97K Hold
20,000
– – ﹤0.01% 1533
2021
Q1 		$104K Buy
+20,000
New +$139K ﹤0.01% 1487

Other funds holding BLPH

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's BLPH Position: Q1 2023 in Review

Tudor Investment Corp sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2023, closing a stake of 20,000 shares — an estimated $18K sold.

Tudor Investment Corp first reported a position in BLPH in Q1 2021 and held it in 8 quarters. The position peaked at $104K in Q1 2021. 19 funds tracked by Wall St. Rank hold BLPH as of Q1 2023.

  • Tudor Investment Corp reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 20,000 Bellerophon Therapeutics, Inc. shares in Q1 2023, an estimated $18K.
  • Tudor Investment Corp first reported a position in Bellerophon Therapeutics, Inc. in Q1 2021 and held it in 8 quarters.
  • Tudor Investment Corp's Bellerophon Therapeutics, Inc. position peaked at $104K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.